Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pleiotrophin drives a prometastatic immune niche in breast cancer.
Ganguly D, Schmidt MO, Coleman M, Ngo TC, Sorrelle N, Dominguez ATA, Murimwa GZ, Toombs JE, Lewis C, Fang YV, Valdes-Mora F, Gallego-Ortega D, Wellstein A, Brekken RA. Ganguly D, et al. Among authors: fang yv. J Exp Med. 2023 May 1;220(5):e20220610. doi: 10.1084/jem.20220610. Epub 2023 Feb 24. J Exp Med. 2023. PMID: 36828390 Free PMC article.
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC, Chang TC, Wang Y, Guo L, Gao Y, Bikorimana E, Lemoff A, Fang YV, Zhang H, Zhang Y, Ye D, Soria-Bretones I, Servetto A, Lee KM, Luo X, Otto JJ, Akamatsu H, Napolitano F, Mani R, Cescon DW, Xu L, Xie Y, Mendell JT, Hanker AB, Arteaga CL. Lin CC, et al. Among authors: fang yv. Nat Commun. 2024 Mar 13;15(1):2287. doi: 10.1038/s41467-024-46495-2. Nat Commun. 2024. PMID: 38480701 Free PMC article.
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC, Chang TC, Wang Y, Guo L, Gao Y, Bikorimana E, Lemoff A, Fang YV, Zhang H, Zhang Y, Ye D, Soria-Bretones I, Servetto A, Lee KM, Luo X, Otto JJ, Akamatsu H, Napolitano F, Mani R, Cescon DW, Xu L, Xie Y, Mendell JT, Hanker AB, Arteaga CL. Lin CC, et al. Among authors: fang yv. Res Sq [Preprint]. 2023 Jul 10:rs.3.rs-2966905. doi: 10.21203/rs.3.rs-2966905/v1. Res Sq. 2023. Update in: Nat Commun. 2024 Mar 13;15(1):2287. doi: 10.1038/s41467-024-46495-2 PMID: 37502925 Free PMC article. Updated. Preprint.
The role of skin ulceration in breast carcinoma staging and outcome.
Khoury T, Gaudioso C, Fang YV, Sanati S, Opyrchal M, Desouki MM, Karabakhtsian RG, Li Z, Wang D, Yan L, Jacobson R. Khoury T, et al. Among authors: fang yv. Breast J. 2018 Jan;24(1):41-50. doi: 10.1111/tbj.12830. Epub 2017 Jun 8. Breast J. 2018. PMID: 28597587 Free PMC article.
Ossifying fibroma of the nose and paranasal sinuses.
Manes RP, Ryan MW, Batra PS, Mendelsohn D, Fang YV, Marple BF. Manes RP, et al. Among authors: fang yv. Int Forum Allergy Rhinol. 2013 Feb;3(2):161-8. doi: 10.1002/alr.21067. Epub 2012 Jun 26. Int Forum Allergy Rhinol. 2013. PMID: 22736440 Review.
Pathology quiz case 1. Cemento-ossifying fibroma (COF).
Manes P, Fang YV, Ryan MW. Manes P, et al. Among authors: fang yv. Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1145, 1147. doi: 10.1001/archoto.2010.198-a. Arch Otolaryngol Head Neck Surg. 2010. PMID: 21079174 No abstract available.
16 results